Bariatric Surgery in Obese Patients With Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 72 of the 78 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: There is a paucity of data on the impact of bariatric surgery in type 1 diabetes (T1D). The aim of this review was to quantify the overall effects of bariatric surgery in obese patients with T1D. METHODS: We searched PubMed, Scopus, ISI Web of Knowledge, and Google Scholar from their inception to December 2015 to identify all relevant studies of bariatric surgery in adult obese patients with T1D. RESULTS: The review included 17 studies with 107 individuals, including 10 case series and 7 case reports. Overall, the dominant procedure was gastric bypass (n = 70; 65%). All studies reported a significant reduction in excess weight. A significant reduction in weight-adjusted daily insulin requirements was shown in all case series except one. Pooled mean ± SD of pre- and postoperative glycated hemoglobin (HbA1c) for the entire cohort with available data (n = 96) was 8.4 ± 1.3% and 7.9 ± 1.1%, respectively (P = 0.01). In addition to common postoperative complications, profound glycemic changes (diabetic ketoacidosis and hypoglycemia) and gastrointestinal dysmotility symptoms (prolonged ileus and acute gastric remnant dilation) have been reported. No surgical mortality was reported. CONCLUSIONS: Bariatric surgery leads to significant weight loss in severely obese patients with T1D and results in a significant improvement in insulin requirements and glycemic status. The favorable metabolic effects of bariatric surgery may facilitate medical management of and cardiovascular risk reduction in T1D in the setting of severe obesity. Diabetic ketoacidosis and hypoglycemia are potentially serious complications. Short-term results of bariatric surgery in patients with T1D are encouraging, but larger and longer-term studies are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · cited 1×
“In appropriate-risk patients with T1D, gastric bypass offers a treatment option with a risk/benefit profile that lies between purely restrictive (gastric banding) and malabsorptive (duodenal switch) procedures (12,19,22,27,49).”
BackgroundBariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401329 · Cited by 1,901 · cited 2×
“complications including cardiovascular diseases, nephropathy, retinopathy, and mortality at long-term follow-up (28), while enhancing patients’ quality of life (22).”
BackgroundSelf-citationBariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200111 · Cited by 1,791
Long-Term Complications of Diabetes Mellitus
Nathan, D. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282306 · Cited by 1,495
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Perioperative safety in the longitudinal assessment of bariatric surgery
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901836 · Cited by 1,392
Epidemiology of type 1 diabetes
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092 · cited 1×
“Large epidemiologic studies indicate that the worldwide incidence of T1D has been increasing in recent decades (1,2).”
BackgroundDaneman, D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68341-4 · Cited by 921
Ikramuddin, S., Korner, J., Lee, W.-J., Connett, J. E., Inabnet, W. B., Billington, C. J., Thomas, A. J., Leslie, D. B., Chong, K., Jeffery, R. W., et al. (2013) · JAMA · doi:10.1001/jama.2013.5835 · Cited by 735
Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
Laing, S. P., Swerdlow, A. J., Slater, S. D., Burden, A. C., Morris, A., Waugh, N. R., Gatling, W., Bingley, P. J., & Patterson, C. C. (2003) · Diabetologia · doi:10.1007/s00125-003-1116-6 · Cited by 724 · cited 1×
“T1D is associated with serious long-term complications that affect the cardiovascular system, eyes, kidneys, and nervous system and predispose to certain infections (3), which can lead to substantial increased mortality rates compared with the nondiabetic population (4,5).”
BackgroundHealth benefits of gastric bypass surgery after 6 years
Adams, T. D., Davidson, L. E., Litwin, S. E., Kolotkin, R. L., LaMonte, M. J., Pendleton, R. C., Strong, M. B., Vinik, R., Wanner, N. A., Hopkins, P. N., et al. (2012) · JAMA · doi:10.1001/2012.jama.11164 · Cited by 674 · cited 1×
“Multiple randomized clinical trials (22–25) and long-term studies (26,27) have shown significant and durable effects of bariatric surgery on type 2 diabetes (T2D), with possible long-term, complete remission of this progressive disease.”
BackgroundBrethauer, S. A., Aminian, A., Romero-Talamás, H., Batayyah, E., Mackey, J., Kennedy, L., Kashyap, S. R., Kirwan, J. P., Rogula, T., Kroh, M., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a5034b · Cited by 552 · cited 2×
“Multiple randomized clinical trials (22–25) and long-term studies (26,27) have shown significant and durable effects of bariatric surgery on type 2 diabetes (T2D), with possible long-term, complete remission of this progressive disease.”
BackgroundSelf-citationHormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery
Thaler, J. P., & Cummings, D. E. (2009) · Endocrinology · doi:10.1210/en.2009-0367 · Cited by 443
Zimmet, P., Tuomi, T., Mackay, I. R., Rowley, M. J., Knowles, W., Cohen, M., & Lang, D. A. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00275.x · Cited by 413 · cited 1×
“The rate of destruction, however, can vary (59,60).”
BackgroundLiu, L. L., Lawrence, J. M., Davis, C., Liese, A. D., Pettitt, D. J., Pihoker, C., Dabelea, D., Hamman, R., Waitzfelder, B., Kahn, H. S., et al. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00519.x · Cited by 402
Metabolic Surgery to Treat Type 2 Diabetes: Clinical Outcomes and Mechanisms of Action
Rubino, F., Schauer, P. R., Kaplan, L. M., & Cummings, D. E. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.051308.105148 · Cited by 381
Self-citationDorman, J. S., Laporte, R. E., Kuller, L. H., Cruickshanks, K. J., Orchard, T. J., Wagener, D. K., Becker, D. J., Cavender, D. E., & Drash, A. L. (1984) · Diabetes · doi:10.2337/diab.33.3.271 · Cited by 350
Bariatric surgery for type 2 diabetes
Dixon, J. B., le Roux, C. W., Rubino, F., & Zimmet, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60401-2 · Cited by 296
Kashyap, S. R., Daud, S., Kelly, K. R., Gastaldelli, A., Win, H., Brethauer, S., Kirwan, J. P., & Schauer, P. R. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.254 · Cited by 274 · cited 1×
“In patients with T2D, bariatric surgery improves pancreatic islet size, function, and survival (61,62).”
BackgroundSelf-citationObesity, insulin resistance, and type 1 diabetes mellitus
Polsky, S., & Ellis, S. L. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000170 · Cited by 235 · cited 3×
“Importantly, several studies have shown that obesity and metabolic syndrome in T1D are associated with the development and progression of micro- and macrovascular complications (8,13,14).”
BackgroundPerkins, B. A., Cherney, D. Z. I., Partridge, H., Soleymanlou, N., Tschirhart, H., Zinman, B., Fagan, N. M., Kaspers, S., Woerle, H.-J., Broedl, U. C., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2338 · Cited by 231
Insulin resistance is a risk factor for progression to Type 1 diabetes
Fourlanos, S., Narendran, P., Byrnes, G. B., Colman, P. G., & Harrison, L. C. (2004) · Diabetologia · doi:10.1007/s00125-004-1507-3 · Cited by 228
Breen, D. M., Rasmussen, B. A., Kokorovic, A., Wang, R., Cheung, G. W. C., & Lam, T. K. T. (2012) · Nature Medicine · doi:10.1038/nm.2745 · Cited by 209 · cited 1×
“ment of T1D showed that a diversionary gastrointestinal procedure (duodenaljejunal bypass surgery) lowers blood glucose concentrations within 2 days after surgery, which occurred independent of weight loss and insulin secretion (69).”
BackgroundThe use of metformin in type 1 diabetes: a systematic review of efficacy
Vella, S., Buetow, L., Royle, P., Livingstone, S., Colhoun, H. M., & Petrie, J. R. (2010) · Diabetologia · doi:10.1007/s00125-009-1636-9 · Cited by 201 · cited 1×
“Some studies have shown that adding metformin (15,16),”
BackgroundType 1 diabetes, metabolic syndrome and cardiovascular risk
Chillarón, J. J., Flores Le-Roux, J. A., Benaiges, D., & Pedro-Botet, J. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.002 · Cited by 195 · cited 1×
“depending on the study population and the diagnostic criteria used (7).”
MethodHow safe is metabolic/diabetes surgery?
Aminian, A., Brethauer, S. A., Kirwan, J. P., Kashyap, S. R., Burguera, B., & Schauer, P. R. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12405 · Cited by 193 · cited 1×
“In appropriate-risk patients with T1D, gastric bypass offers a treatment option with a risk/benefit profile that lies between purely restrictive (gastric banding) and malabsorptive (duodenal switch) procedures (12,19,22,27,49).”
BackgroundSelf-citation7. Approaches to Glycemic Treatment
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s010 · Cited by 181
Kielgast, U., Krarup, T., Holst, J. J., & Madsbad, S. (2011) · Diabetes Care · doi:10.2337/dc11-0096 · Cited by 165 · cited 1×
“The treatment effect was larger in patients with residual b-cell function (with detectable C-peptide), and some patients were able to discontinue insulin treatment (68).”
BackgroundBariatric surgery: an IDF statement for obese Type 2 diabetes
Dixon, J. B., Zimmet, P., Alberti, K. G. M. M., & Rubino, F. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.05.013 · Cited by 146
Impact of Overweight on Chronic Microvascular Complications in Type 1 Diabetic Patients
De Block, C. E. M., De Leeuw, I. H., & Van Gaal, L. F. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1649 · Cited by 138
Couper, J. J., Beresford, S., Hirte, C., Baghurst, P. A., Pollard, A., Tait, B. D., Harrison, L. C., & Colman, P. G. (2009) · Diabetes Care · doi:10.2337/dc08-0821 · Cited by 103
Diabetes remission after bariatric surgery: is it just the incretins?
Laferrère, B. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.143 · Cited by 88
Exploring the impact of bariatric surgery on high density lipoprotein
Aminian, A., Zelisko, A., Kirwan, J. P., Brethauer, S. A., & Schauer, P. R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.07.017 · Cited by 86
Self-citationDevelopment of a sleeve gastrectomy risk calculator
Aminian, A., Brethauer, S. A., Sharafkhah, M., & Schauer, P. R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.012 · Cited by 82
Self-citationGastric Bypass Improves β-Cell Function and Increases β-Cell Mass in a Porcine Model
Lindqvist, A., Spégel, P., Ekelund, M., Garcia‐Vaz, E., Pierzynowski, S. G., Gomez, M. F., Mulder, H., Hedenbro, J., Groop, L., & Wierup, N. (2014) · Diabetes · doi:10.2337/db13-0969 · Cited by 80
Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes
Price, S. A., Gorelik, A., Fourlanos, S., Colman, P. G., & Wentworth, J. M. (2014) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.03.007 · Cited by 77 · cited 3×
“Importantly, several studies have shown that obesity and metabolic syndrome in T1D are associated with the development and progression of micro- and macrovascular complications (8,13,14).”
BackgroundRisk prediction of complications of metabolic syndrome before and 6 years after gastric bypass
Aminian, A., Daigle, C. R., Romero‐Talamás, H., Kashyap, S. R., Kirwan, J. P., Brethauer, S. A., & Schauer, P. R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.01.025 · Cited by 75 · cited 1×
“complications including cardiovascular diseases, nephropathy, retinopathy, and mortality at long-term follow-up (28), while enhancing patients’ quality of life (22).”
BackgroundSelf-citationExenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes
Sarkar, G., Alattar, M., Brown, R. J., Quon, M. J., Harlan, D. M., & Rother, K. I. (2014) · Diabetes Care · doi:10.2337/dc13-1473 · Cited by 74
Adiposity and mortality in type 1 diabetes
Conway, B., Miller, R. G., Costacou, T., Fried, L., Kelsey, S., Evans, R. W., & Orchard, T. J. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.75 · Cited by 73 · cited 1×
“It is expected that the need for bariatric surgery in patients with T1D will increase in the future, since the prevalence of severe obesity among this population has considerably increased during the past decade (70).”
BackgroundThe effect of bariatric surgery on gout: a comparative study
Romero‐Talamás, H., Daigle, C. R., Aminian, A., Corcelles, R., Brethauer, S. A., & Schauer, P. R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.02.025 · Cited by 73
Self-citationIncidence and Clinical Features of Diabetic Ketoacidosis After Bariatric and Metabolic Surgery
Aminian, A., Kashyap, S. R., Burguera, B. G., Punchai, S., Sharma, G., Froylich, D., Brethauer, S. A., & Schauer, P. R. (2016) · Diabetes Care · doi:10.2337/dc15-2647 · Cited by 64 · cited 1×
“The incidence of postoperative DKA is 20–25% in some reports (32,57).”
BackgroundSelf-citationPsoriasis improvement after bariatric surgery
Romero‐Talamás, H., Aminian, A., Corcelles, R., Fernandez, A. P., Schauer, P. R., & Brethauer, S. A. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.03.025 · Cited by 59
Self-citationBariatric Surgery Improves the Metabolic Profile of Morbidly Obese Patients With Type 1 Diabetes
Brethauer, S. A., Aminian, A., Rosenthal, R. J., Kirwan, J. P., Kashyap, S. R., & Schauer, P. R. (2014) · Diabetes Care · doi:10.2337/dc13-1736 · Cited by 53
Self-citationLong-Term Results of Gastric Bypass Surgery in Morbidly Obese Type 1 Diabetes Patients
Czupryniak, L., Wiszniewski, M., Szymański, D., Pawłowski, M., Loba, J., & Strzelczyk, J. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0074-6 · Cited by 50 · cited 3×
“ketoacidosis [DKA] and severe hypoglycemia) following surgery have been reported in this population (30,32,38,39,43).”
BackgroundFailed Surgical Weight Loss Does Not Necessarily Mean Failed Metabolic Effects
Aminian, A., Jamal, M., Augustin, T., Corcelles, R., Kirwan, J. P., Schauer, P. R., & Brethauer, S. A. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0064 · Cited by 46
Self-citationShould metabolic surgery be offered in morbidly obese patients with type I diabetes?
Robert, M., Belanger, P., Hould, F., Marceau, S., Tchernof, A., & Biertho, L. D. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.016 · Cited by 44 · cited 6×
“Improvement in lipid profile (30–33,38,39,41–44) and blood pressure (30,31,38,39,41,45) was shown in some studies.”
BackgroundResultInfluentialBariatric surgery and diabetes: Implications of type 1 versus insulin‐requiring type 2
Maraka, S., Kudva, Y. C., Kellogg, T. A., Collazo‐Clavell, M. L., & Mundi, M. S. (2015) · Obesity · doi:10.1002/oby.20992 · Cited by 42
Update: Why Diabetes Does Not Resolve in Some Patients after Bariatric Surgery
Deitel, M. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0329-2 · Cited by 40 · cited 1×
“be that the patient actually had undiagnosed autoimmune diabetes, not T2D (48).”
BackgroundLannoo, M., Dillemans, B., Van Nieuwenhove, Y., Fieuws, S., Mathieu, C., Gillard, P., D’Hoore, A., & Van Der Schueren, B. (2014) · Diabetes Care · doi:10.2337/dc14-0583 · Cited by 40 · cited 2×
“and fat-soluble nutrients and might thus be a good option for postoperative glycemicmanagement and reducing the risk of hypoglycemia in patients with T1D (29).”
BackgroundBariatric Surgery for Severe Obesity in Two Adolescents With Type 1 Diabetes
Chuang, J., Zeller, M. H., Inge, T. H., & Crimmins, N. A. (2013) · PEDIATRICS · doi:10.1542/peds.2012-3640 · Cited by 35 · cited 9×
“Perioperative and long-term postsurgical management of diabetes by an endocrinologist or a diabetes educator is indicated to minimize the risk of metabolic complications related to hypoglycemic episodes and DKA.”
BackgroundInfluentialCan Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus?
Hussain, A., Mahmood, H., & El‐Hasani, S. (2009) · PubMed · Cited by 34
Relevance of beta-cell function for improved glycemic control after gastric bypass surgery
Blanco, J., Jiménez, A., Casamitjana, R., Flores, L., Lacy, A. M., Conget, I., & Vidal, J. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.07.020 · Cited by 33 · cited 5×
“The incretin mechanism may also contribute to improved glucose metabolism in patients with T1D after bariatric surgery (35,42) by inhibiting glucagon secretion even in the absence of residual b-cells.”
BackgroundResultInfluentialTanenberg, R. J., Tanenberg, R. J., & Pories, W. J. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s9981 · Cited by 30
Burchardt, P., Zawada, A., Tabaczewski, P., Naskręt, D., Kaczmarek, J., Marcinkaniec, J., Wierusz‑Wysocka, B., & Wysocki, H. (2013) · Polish Archives of Internal Medicine · doi:10.20452/pamw.1925 · Cited by 28 · cited 1×
“Some studies have shown that adding metformin (15,16),”
BackgroundGastric Bypass Surgery in Severely Obese Type 1 Diabetic Patients
Czupryniak, L., Strzelczyk, J., Cypryk, K., Pawlowski, M., Szymański, D., Lewiñski, A., & Loba, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2561 · Cited by 27 · cited 1×
“The first case report and series were published in 2004 (46) and 2008 (34), respectively.”
BackgroundIs Laparoscopic Bariatric Surgery a Safe Option in Extremely High-Risk Morbidly Obese Patients?
Aminian, A., Jamal, M. H., Andalib, A., Batayyah, E., Romero‐Talamás, H., Chand, B., Schauer, P. R., & Brethauer, S. A. (2015) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2015.0013 · Cited by 24
Self-citationObesity and metabolic surgery in type 1 diabetes mellitus.
Raab, H., Weiner, R. A., Frenken, M., Kristian, R. E. T. T., & Weiner, S. R. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6711 · Cited by 22
Dirksen, C., Jacobsen, S. H., Bojsen-Møller, K. N., Jørgensen, N. B., Naver, L., Hvolris, L., Worm, D., Madsbad, S., Holst, J. J., & Hansen, D. L. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.01.002 · Cited by 22 · cited 1×
“The incretin mechanism may also contribute to improved glucose metabolism in patients with T1D after bariatric surgery (35,42) by inhibiting glucagon secretion even in the absence of residual b-cells.”
BackgroundMiddelbeek, R. J. W., James-Todd, T. M., Patti, M., & Brown, F. M. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1228-8 · Cited by 22 · cited 5×
“Perioperative and long-term postsurgical management of diabetes by an endocrinologist or a diabetes educator is indicated to minimize the risk of metabolic complications related to hypoglycemic episodes and DKA.”
BackgroundInfluentialBariatric surgery in type 1 diabetes
Reyes‐García, R., Muñoz, M. R., & Verdú, H. G. (2013) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2013.01.003 · Cited by 21
Chmura, A. (2014) · Annals of Transplantation · doi:10.12659/aot.892954 · Cited by 21 · cited 2×
“Improvement in lipid profile (30–33,38,39,41–44) and blood pressure (30,31,38,39,41,45) was shown in some studies.”
BackgroundGarcía-Caballero, M., Martínez-Moreno, J. M., Toval, J. A., Miralles, F., Mínguez, A., Osorio, D., Mata, J. M., & Reyes-Ortiz, A. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6712 · Cited by 20 · cited 5×
“All but one study included only severely obese patients; the exception included less obese patients with an average BMI of 29 kg/m(2) (38).”
BackgroundInfluentialRemission of Diabetes after Laparoscopic Gastric Bypass
Smith, B. R., Hinojosa, M. W., Reavis, K. M., & Nguyen, N. T. (2008) · The American Surgeon™ · doi:10.1177/000313480807401014 · Cited by 20 · cited 1×
“The first case report and series were published in 2004 (46) and 2008 (34), respectively.”
BackgroundHan, S. H., White, S. I., Patel, K., Dutson, E., Gracia, C. R., & Mehran, A. (2006) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2006.08.005 · Cited by 19 · cited 1×
“toms such as prolonged ileus, intractable nausea and vomiting (30), and acute gastric remnant dilation (58) have also been reported in patients with T1D after bariatric surgery.”
BackgroundBariatric surgery in type 1 diabetes mellitus; long-term experience in two cases.
Zamorano, N. F., Sánchez-Pernaute, A., García, A. J. T., & Rubio, M. Á. (2013) · PubMed · doi:10.3305/nh.2013.28.4.6605 · Cited by 15 · cited 3×
“Improvement in lipid profile (30–33,38,39,41–44) and blood pressure (30,31,38,39,41,45) was shown in some studies.”
BackgroundMiddelbeek, R. J. W., James-Todd, T. M., Cavallerano, J. D., Schlossman, D. K., Patti, M., & Brown, F. M. (2015) · Diabetes Care · doi:10.2337/dc15-0396 · Cited by 15 · cited 1×
“and microalbuminuria (30,33,38,39,45), retinopathy (33), and quality of life (38,41,43) after surgery.”
BackgroundCirugía bariátrica en el paciente con diabetes mellitus tipo 1
Reyes‐García, R., Muñoz, M. R., & Verdú, H. G. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.01.021 · Cited by 13
Kirwan, J. P., Brethauer, S. A., Aminian, A., Rosenthal, R. J., Kashyap, S. R., & Schauer, P. R. (2014) · Diabetes Care · doi:10.2337/dc14-1769 · Cited by 12
Self-citationTang, A., Milner, K., Tonks, K. T. T., Campbell, L. V., & Greenfield, J. R. (2014) · Diabetes Care · doi:10.2337/dc14-0578 · Cited by 11
Franck, M., Paquot, N., & Scheen, A. J. (2012) · PubMed · Cited by 5
Comment on: Should metabolic surgery be offered in morbidly obese patients with type I diabetes?
COHEN, R. V. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.01.020 · Cited by 5 · cited 1×
“In appropriate-risk patients with T1D, gastric bypass offers a treatment option with a risk/benefit profile that lies between purely restrictive (gastric banding) and malabsorptive (duodenal switch) procedures (12,19,22,27,49).”
Background
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
“In addition, metabolic surgery in appropriate candidates can decrease body weight and improve glycemia (197,198).”
O'Kane, M., Parretti, H. M., Pinkney, J., Welbourn, R., Hughes, C. A., Mok, J., Walker, N., Thomas, D., Devin, J., Coulman, K. D., et al. (2020) · Obesity Reviews · doi:10.1111/obr.13087 · Cited by 338
Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity
Aminian, A., Brethauer, S. A., Andalib, A., Nowacki, A. S., Jimenez, A., Corcelles, R., Hanipah, Z. N., Punchai, S., Bhatt, D. L., Kashyap, S. R., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002407 · Cited by 256
Self-citationAmerican Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s008 · Cited by 244
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s008 · Cited by 244
Metadata
- Authors
- Kirwan, J. P., Aminian, A., Kashyap, S. R., Burguera, B., Brethauer, S. A., & Schauer, P. R.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Aminian, Ali
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-05-13
- Volume
- 39
- Issue
- 6
- Pages
- 941-948
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC8310563
- OpenAlex
- W2400544139
- Cited by
- 80
- References
- 78
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 13 · 2020: 11 · 2019: 10 · 2018: 6 · 2017: 10 · 2016: 5
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- bariatric surgery, type 1 diabetes, obesity, gastric bypass, weight loss, insulin requirement, HbA1c, glycemic control, diabetic ketoacidosis, hypoglycemia, gastrointestinal motility disorders, postoperative complications
- MeSH terms
- Adult, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Obesity, Postoperative Complications, Risk Factors, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.